The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $82.12

Today's change+0.39 +0.48%
Updated September 20 10:43 AM EDT. Delayed by at least 15 minutes.
 

Eli Lilly and Co

NYSE: LLY
Last

(U.S.) $82.12

Today's change+0.39 +0.48%
Updated September 20 10:43 AM EDT. Delayed by at least 15 minutes.

Eli Lilly and Co crosses above 125-day moving average

Eli Lilly and Co is up today by (U.S.)$0.39 or 0.48% to (U.S.)$82.12 and crossing above its 125-day moving average. Shares have lost 0.38% over the last five days, but have gained 11.65% over the last year to date. This security has underperformed the S&P 500 by 14.36% during the last year.

Key company metrics

  • Open(U.S.) $82.06
  • Previous close(U.S.) $81.73
  • High(U.S.) $82.42
  • Low(U.S.) $81.90
  • Bid / Ask(U.S.) $82.12 / (U.S.) $82.19
  • YTD % change+11.65%
  • Volume237,232
  • Average volume (10-day)3,551,469
  • Average volume (1-month)3,374,188
  • Average volume (3-month)3,589,530
  • 52-week range(U.S.) $64.18 to (U.S.) $86.72
  • Beta0.32
  • Trailing P/E35.59×
  • P/E 1 year forward19.64×
  • Forward PEG1.72×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.53%
  • Trailing EPS(U.S.) $2.31
Updated September 20 10:43 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue5,8245,2285,7615,192
Total other revenue--------
Total revenue5,8245,2285,7615,192
Gross profit4,2733,9014,2953,791
Total cost of revenue1,5521,3281,4661,401
Total operating expense4,5605,1824,8844,248
Selling / general / administrative1,7071,5451,7901,565
Research & development1,2511,2381,4511,236
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)501,07217846
Other operating expenses, total--------
Operating income1,26446876944
Interest income (expense), net non-operating-70-58-61-58
Gain (loss) on sale of assets--------
Other--------
Income before tax1,26161892971
Income after tax1,008-111772778
Income tax, total253172120193
Net income1,008-111772778
Total adjustments to net income--------
Net income before extra. items1,008-111772778
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,008-111772778
Inc. avail. to common incl. extra. items1,008-111772778
Diluted net income1,008-111772778
Dilution adjustment--------
Diluted weighted average shares1,0571,0561,0641,061
Diluted EPS excluding extraordinary itemsvalue per share0.95-0.100.730.73
Dividends per sharevalue per share0.520.520.510.51
Diluted normalized EPSvalue per share0.990.840.870.77